ArticleCardiovascular research2025

A novel long-acting relaxin-2 fusion, AZD3427, improves cardiac performance in non-human primates with cardiac dysfunction.

Monika Papworth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.